Read more
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Medical scientists have highlighted that Statin has the capacity to reduce the risk of death in patients with hepatocellular cancer. Indeed, official medical figures have shown that the patients of hepatocellular carcinoma who used statins in addition to local and systemic therapy or surgical resection had a 30% reduction in mortality. On the other hand, medical reports have shown that the sufferers of hepatocellular carcinoma have a poor diagnosis rate, due to the disease s symptoms tending to only emerge in the advanced stages of the disease. Meanwhile, disease awareness has also proved to be also low due to a lack of public and professional understanding, with no mandatory screening guidelines even existing for hepatocellular carcinoma diagnosis. Medical professionals have advanced that hepatocellular cancer is a very vascular disease as well as the most common form of liver cancer. The most common symptoms of the hepatocellular carcinoma are jaundice, nausea, loss of appetite, abdominal pain...
